Drug:
Reaction: COUGH
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26935821 |
CN |
23 | 2 |
Drug eruption, Asthenia, Night sweats, Headache, Oropharyngeal pain, Cough, Rash macular, Conjunctival hyperaemia, Mucosal erosion, Ulcer haemorrhage, Macule, Pyrexia, Perineal erythema, Epidermolysis, Off label use, |
||||
LAMOTRIGINE, SERTRALINE, OLANZAPINE, |
||||
| 102 | 26935952 |
ZA |
40 | 2 |
Gastroenteritis viral, Fatigue, Peripheral motor neuropathy, Malaise, Paraesthesia, Nasopharyngitis, Influenza, Cough, |
||||
FINGOLIMOD HYDROCHLORIDE, ZOLPIDEM TARTRATE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, QUETIAPINE, AMLODIPINE BESYLATE AND OLMESARTAN MEDOXOMIL, |
||||
| 103 | 26935956 |
JP |
75 | 2 |
Ureterolithiasis, Musculoskeletal stiffness, Poor quality sleep, Cough, Productive cough, Frequent bowel movements, Chest discomfort, Dyspnoea exertional, Fatigue, Fatigue, Abnormal sensation in eye, Nausea, Feeling abnormal, Dry mouth, Neuralgia, |
||||
NINTEDANIB, NINTEDANIB, |
||||
| 104 | 26935976 |
US |
2 | |
Lung neoplasm malignant, Cough, Wheezing, Product use in unapproved indication, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, AMLODIPINE BESYLATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALCAFTADINE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LORAZEPAM, MAGNESIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, SERTRALINE HYDROCHLORIDE, ERGOCALCIFEROL, |
||||
| 105 | 26935998 |
US |
65 | 1 |
Lower respiratory tract infection, Cough, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 106 | 26936040 |
EU |
72 | 1 |
Cough, Chest pain, |
||||
CARBOPLATIN, |
||||
| 107 | 26936076 |
CA |
27 | 2 |
Crohn^s disease, Rhinorrhoea, Pruritus, Cough, Proctitis, Alopecia, Abscess, COVID-19, Rash macular, Peripheral swelling, Pyrexia, Inappropriate schedule of product administration, Off label use, |
||||
ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, ADALIMUMAB-RYVK, |
||||
| 108 | 26936330 |
US |
81 | 1 |
Cough, Productive cough, Dyspnoea, Skin discolouration, Accidental exposure to product, Exposure via skin contact, |
||||
DUPILUMAB, |
||||
| 109 | 26936561 |
US |
2 | |
Asthma, Cough, Wheezing, Dyspnoea, Chest discomfort, Insomnia, |
||||
BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, BENRALIZUMAB, |
||||
| 110 | 26936683 |
US |
||
Cough, Fatigue, Drug ineffective, |
||||
ORFORGLIPRON, |
||||
| 111 | 26936812 |
US |
73 | 2 |
Neuropathy peripheral, Condition aggravated, Platelet count decreased, Throat irritation, Cough, Suspected off label use, |
||||
PALBOCICLIB, PALBOCICLIB, PALBOCICLIB, ALLOPURINOL, AMLODIPINE, EXEMESTANE, VITAMIN C, DULOXETINE HYDROCHLORIDE, DULOXETINE, HYDROXYCHLOROQUINE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, MOMETASONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PROCHLORPERAZINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 112 | 26936934 |
EU |
77 | 1 |
Obstructive airways disorder, Myoglobin blood increased, Coronary artery disease, Obstructive sleep apnoea syndrome, Plantar fasciitis, Chest discomfort, Secretion discharge, Dysphonia, Dyspnoea exertional, Cardiac disorder, Eosinophilia, Wheezing, Fractional exhaled nitric oxide increased, Brain natriuretic peptide increased, Sensation of foreign body, Exostosis, Pneumothorax, Myoglobin blood increased, Obstructive airways disorder, Atrial fibrillation, Dyspnoea, Plantar fasciitis, Chest discomfort, Increased upper airway secretion, Bronchospasm, Foreign body in throat, Cough, Muscle spasms, Muscle spasms, Nasopharyngitis, Nasopharyngitis, |
||||
EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, BIOTIN, BIOTIN, BIOTIN, BIOTIN, BIOTIN, BIOTIN, BIOTIN, BIOTIN, BIOTIN, BIOTIN, BIOTIN, CALCIUM, CALCIUM, CALCIUM, CALCIUM, CALCIUM, DICLOFENAC SODIUM, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, TADALAFIL, TADALAFIL, ROSUVASTATIN CALCIUM, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ROSUVASTATIN, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, CLOPIDOGREL, CLOPIDOGREL BISULFATE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, DICLOFENAC EPOLAMINE, DICLOFENAC EPOLAMINE, COLESEVELAM, COLESEVELAM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL, OLMESARTAN MEDOXOMIL, COLESEVELAM HYDROCHLORIDE, COLESEVELAM HYDROCHLORIDE, COLESEVELAM HYDROCHLORIDE, COLESEVELAM HYDROCHLORIDE, COLESEVELAM HYDROCHLORIDE, COLESEVELAM HYDROCHLORIDE, COLESEVELAM HYDROCHLORIDE, COLESEVELAM HYDROCHLORIDE, COLESEVELAM HYDROCHLORIDE, COLESEVELAM HYDROCHLORIDE, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, ROSUVASTATIN, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, RIVAROXABAN, ALIROCUMAB, ALIROCUMAB, ALIROCUMAB, ALIROCUMAB, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, TADALAFIL, TADALAFIL, TADALAFIL, ERGOCALCIFEROL, MOMETASONE, MOMETASONE, MOMETASONE, MOMETASONE, MOMETASONE, VITAMIN E, VITAMIN E, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, FLUTICASONE PROPIONATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALIROCUMAB, ERGOCALCIFEROL, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, IPRATROPIUM BROMIDE, RIVAROXABAN, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, EVOLOCUMAB, CALCIUM CARBONATE, ANTACID, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, EUCALYPTUS GLOBULUS LEAF, PEPPERMINT OIL, |
||||
| 113 | 26937060 |
CA |
33 | |
Chest pain, Pneumonia, Pyrexia, Cough, Drug effect less than expected, Therapy interrupted, Off label use, Intentional dose omission, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, MONTELUKAST, |
||||
| 114 | 26937110 |
US |
1 | |
Cough, |
||||
DUPILUMAB, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, UPADACITINIB, TAMSULOSIN HYDROCHLORIDE, |
||||
| 115 | 26937198 |
US |
26 | 1 |
Dyspnoea, Cough, Product complaint, |
||||
CABOTEGRAVIR AND RILPIVIRINE, CABOTEGRAVIR AND RILPIVIRINE, |
||||
| 116 | 26937330 |
US |
1 | |
Cough, Oropharyngeal discomfort, |
||||
SPARSENTAN, SPARSENTAN, |
||||
| 117 | 26937503 |
US |
56 | 2 |
Cough, |
||||
DUPILUMAB, |
||||
| 118 | 26937570 |
US |
14 | 1 |
Throat irritation, Cough, |
||||
ETEPLIRSEN, |
||||
| 119 | 26937683 |
US |
1 | |
Nasopharyngitis, Malaise, Cough, |
||||
ETEPLIRSEN, |
||||
| 120 | 26937744 |
US |
81 | 2 |
Cough, Dyspnoea, Hypotension, Chills, |
||||
DONANEMAB-AZBT, |
||||
| 121 | 26937925 |
US |
62 | 2 |
Knee arthroplasty, Oral candidiasis, Rhinorrhoea, Cough, |
||||
DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, AMLODIPINE BESYLATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BENZONATATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, FOLIC ACID, FUROSEMIDE, GABAPENTIN, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, METHOTREXATE, METHOTREXATE SODIUM, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, ONDANSETRON HYDROCHLORIDE, OXYGEN, 0XYGEN, |
||||
| 122 | 26937979 |
CA |
42 | 1 |
Pneumonia, Cough, Sputum retention, Dizziness, Sputum discoloured, |
||||
MOXIFLOXACIN, MOXIFLOXACIN HYDROCHLORIDE, PREDNISONE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 123 | 26937996 |
US |
77 | 1 |
Appendicectomy, Cough, |
||||
RISANKIZUMAB-RZAA, |
||||
| 124 | 26938049 |
US |
64 | 2 |
Drug dose omission by device, Device difficult to use, Cough, |
||||
EVOLOCUMAB, |
||||
| 125 | 26938087 |
US |
2 | |
Cough, Chest pain, Pyrexia, Chills, |
||||
SPARSENTAN, |
||||
| 126 | 26938102 |
GB |
2 | |
Lower respiratory tract infection, Lethargy, Malaise, Cough, |
||||
TOBRAMYCIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, PANCRELIPASE, ERGOCALCIFEROL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 127 | 26938276 |
US |
2 | |
Chronic kidney disease, Asthma, Pain, Thyroid disorder, Hypertension, Motion sickness, Osteoporosis, Wheezing, Dyspnoea, Cough, Pulmonary mass, |
||||
| 128 | 26938584 |
US |
2 | |
Cough, Fatigue, Asthenia, Dyspnoea exertional, Infection, Headache, |
||||
BRENSOCATIB, |
||||
| 129 | 26938588 |
US |
2 | |
Chronic obstructive pulmonary disease, Cough, Depression, Retching, Asthenia, Somnolence, Hypersensitivity, Off label use, |
||||
BRENSOCATIB, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BENZONATATE, CICLOPIROX, FLUTICASONE PROPIONATE, LATANOPROST, METOPROLOL TARTRATE, METOPROLOL, METOPROLOL TARTRATE INJECTION, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RIFAMPIN, ROSUVASTATIN, TIOTROPIUM BROMIDE AND OLODATEROL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, |
||||
| 130 | 26938589 |
US |
1 | |
Cough, Fatigue, Product storage error, |
||||
BRENSOCATIB, INDAPAMIDE, CANDESARTAN, LEVOTHYROXINE SODIUM, FINASTERIDE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, AZELASTINE, ALBUTEROL SULFATE, ALBUTEROL, ERGOCALCIFEROL, LORATADINE, LORATADINE ORAL, |
||||
| 131 | 26938724 |
CA |
62 | 2 |
Death, Drug ineffective, Cough, Fatigue, Haemoglobin decreased, Hypotension, Influenza, Pneumonia, Joint swelling, Muscular weakness, Nasal congestion, Osteoarthritis, Dehydration, Rheumatoid arthritis, SARS-CoV-2 test positive, Heart rate increased, Pulmonary oedema, Sinusitis, Skin cancer, Symptom recurrence, Product dose omission issue, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, |
||||
| 132 | 26938759 |
US |
||
Pseudomonas infection, Sputum discoloured, Increased viscosity of upper respiratory secretion, Cough, Feeling abnormal, Product preparation issue, Drug dose omission by device, Device difficult to use, Device defective, |
||||
| 133 | 26938833 |
US |
78 | |
Unevaluable event, Angiopathy, Burn oesophageal, Weight decreased, Wheezing, Oxygen saturation decreased, Blood pressure decreased, Cough, Dizziness, Headache, Incorrect route of product administration, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, MECLIZINE HYDROCHLORIDE, MECLIZINE, MECLIZINE HYDROCLORIDE, VALSARTAN, VALSARTAN ORAL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, MIRTAZAPINE, INSULIN GLARGINE, BUSPIRONE HYDROCHLORIDE, CLOPIDOGREL, CLOPIDOGREL BISULFATE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, SILDENAFIL CITRATE, SILDENAFIL, DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE, DIPHENHYDRAMINE HCL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, TIRZEPATIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FERROUS SULFATE, OXYGEN, 0XYGEN, MUPIROCIN, MUPIROCIN CALCIUM, FUROSEMIDE, CANAGLIFLOZIN, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, DULOXETINE HYDROCHLORIDE, DULOXETINE, MIRABEGRON, RANOLAZINE, |
||||
| 134 | 26938854 |
CA |
80 | 2 |
Oedema peripheral, Cardiac failure congestive, Dyspnoea, Grunting, Breath sounds abnormal, Cough, Secretion discharge, Dyspnoea, Weight decreased, Productive cough, Dyspnoea exertional, Joint swelling, Anxiety, Chest discomfort, Dyspnoea, Heart rate irregular, Oedema peripheral, Rales, Peripheral swelling, Obstructive airways disorder, Erythema, Rales, Oedema, Asthma, Inappropriate schedule of product administration, Off label use, Crepitations, Fatigue, Sleep disorder, |
||||
DUPILUMAB, DUPILUMAB, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, FUROSEMIDE, VALSARTAN, VALSARTAN ORAL, ALBUTEROL SULFATE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, FUROSEMIDE, ACETYLCYSTEINE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, |
||||
| 135 | 26938891 |
EU |
8 | 1 |
Rhinovirus infection, Pseudomonas test positive, Staphylococcus test positive, Klebsiella test positive, Serratia test positive, Pyrexia, Chest X-ray abnormal, Inguinal hernia, Tachypnoea, Infective pulmonary exacerbation of cystic fibrosis, Cough, Sweat test abnormal, Dyspnoea, |
||||
LUMACAFTOR AND IVACAFTOR, LUMACAFTOR AND IVACAFTOR, |
||||
| 136 | 26939386 |
US |
2 | |
Cough, Headache, |
||||
ABALOPARATIDE, |
||||
| 137 | 26939424 |
US |
2 | |
Memory impairment, Cough, Back pain, Product dose omission issue, |
||||
ABALOPARATIDE, ABALOPARATIDE, LISINOPRIL, |
||||
| 138 | 26939432 |
JP |
9 | 1 |
Duodenal ulcer, Oropharyngeal pain, Cough, Malignant neoplasm progression, Inappropriate schedule of product administration, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 139 | 26939488 |
US |
2 | |
Cough, |
||||
ABALOPARATIDE, |
||||
| 140 | 26939643 |
US |
2 | |
Sneezing, Nasal congestion, Cough, |
||||
ABALOPARATIDE, |
||||
| 141 | 26939702 |
US |
1 | |
Hypersomnia, Apathy, Cough, Decreased interest, Headache, Fatigue, Dyspnoea, |
||||
ABALOPARATIDE, ABALOPARATIDE, |
||||
| 142 | 26942885 |
46 | 1 | |
Cough, Oropharyngeal pain, Loss of personal independence in daily activities, Therapy cessation, |
||||
ORFORGLIPRON, ORFORGLIPRON, LOSARTAN, IRON, VITAMIN C, MAGNESIUM, |
||||
| 143 | 26942898 |
2 | ||
Frustration tolerance decreased, Cough, Oropharyngeal pain, Product dispensing issue, |
||||
PALBOCICLIB, |
||||
| 144 | 26945562 |
2 | ||
Dizziness, Headache, Cough, Throat irritation, Pain in extremity, Myalgia, Pain in extremity, Gait disturbance, Fall, |
||||
SILDENAFIL CITRATE, SILDENAFIL, |
||||
| 145 | 26931123 |
IN |
63 | 2 |
Vascular device infection, Off label use, Cough, Fatigue, Disease progression, |
||||
ATEZOLIZUMAB, ATEZOLIZUMAB, |
||||
| 146 | 26931212 |
US |
6 | 1 |
Cough, Respiratory tract congestion, Productive cough, Dyspnoea, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 147 | 26931272 |
US |
2 | |
Asthma prophylaxis, Cough, Chest discomfort, Product leakage, |
||||
TEZEPELUMAB-EKKO, TEZEPELUMAB-EKKO, |
||||
| 148 | 26931453 |
US |
62 | 1 |
Cough, Productive cough, Dyspnoea, |
||||
DUPILUMAB, |
||||
| 149 | 26931667 |
EU |
||
Septic shock, Off label use, Metabolic disorder, Fatigue, Mental disorder, Atrial fibrillation, Injury, Neutropenia, Urinary tract infection, Angiopathy, COVID-19, Benign neoplasm, Infusion related reaction, Renal disorder, COVID-19 pneumonia, Dyspnoea, Poisoning, Procedural complication, Nausea, Vision blurred, Neoplasm malignant, Neoplasm, Dry eye, Anaemia, Oedema peripheral, Arthralgia, Skin disorder, Hypertension, Cyst, Urinary tract disorder, Eye irritation, Pneumonia, Malnutrition, Diarrhoea, Cough, Infestation, Polyp, General symptom, Cardiac disorder, Spinal disorder, Investigation abnormal, Gastrointestinal disorder, Nervous system disorder, Respiratory disorder, Musculoskeletal disorder, Adverse event, Lymphatic disorder, Eye disorder, Administration site reaction, Mediastinal disorder, Blood disorder, Infection, Connective tissue disorder, |
||||
IBRUTINIB, RITUXIMAB, |
||||
| 150 | 26931690 |
US |
51 | 2 |
Fatigue, Cough, |
||||
| 151 | 26931695 |
US |
47 | 1 |
Gastrooesophageal reflux disease, Eructation, Cough, |
||||
OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, |
||||
| 152 | 26931826 |
IN |
58 | 2 |
Death, Neutrophil count decreased, Metastases to central nervous system, White blood cell count decreased, Haemoglobin decreased, Red blood cell count decreased, Platelet count decreased, Headache, Ear pain, Cough, Memory impairment, Amnesia, Swelling face, |
||||
PALBOCICLIB, PALBOCICLIB, FULVESTRANT, LEVETIRACETAM, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, FULVESTRANT, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, |
||||
| 153 | 26932083 |
US |
68 | 2 |
Viral infection, Cough, Nasal congestion, Asthma, Chest discomfort, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 154 | 26932102 |
US |
67 | 2 |
Cardiomegaly, Pathological fracture, Alcohol abuse, Mitral valve incompetence, Hyperkalaemia, Aortic valve incompetence, Lumbosacral plexus lesion, Lyme disease, Type 2 diabetes mellitus, Type IIa hyperlipidaemia, Arteriosclerosis coronary artery, Carotid artery stenosis, Carotid artery occlusion, Fatigue, Enzyme level abnormal, Upper respiratory tract infection, Urinary tract infection, Osteoarthritis, Diabetic vascular disorder, Essential hypertension, Headache, Peripheral vascular disorder, Cerumen impaction, Ill-defined disorder, Angiopathy, Viral infection, Dermatitis contact, Seasonal allergy, Cough, Back pain, Respiratory disorder, Hypernatraemia, Blood osmolarity increased, Aortic valve stenosis, Epicondylitis, Body mass index abnormal, Vitamin D deficiency, Hypercalcaemia, Treatment noncompliance, Rhinitis allergic, |
||||
DENOSUMAB, DENOSUMAB, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ENALAPRIL MALEATE, ENALAPRIL, SITAGLIPTIN, ATORVASTATIN CALCIUM, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, DESOXIMETASONE, CIPROFLOXACIN HYDROCHLORIDE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, |
||||
| 155 | 26932188 |
CA |
76 | |
Macular degeneration, Cough, Dyspnoea, Nasopharyngitis, Underdose, Inappropriate schedule of product administration, Off label use, Product dose omission issue, Intentional dose omission, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, |
||||
| 156 | 26932351 |
CA |
69 | 1 |
Sputum discoloured, Bronchitis, Irritable bowel syndrome, Pneumonia, Dyspnoea, Influenza like illness, Gastrointestinal disorder, Cough, Secretion discharge, Sinusitis, Drug ineffective, |
||||
AMOXICILLIN AND CLAVULANATE POTASSIUM, MEPOLIZUMAB, CLOPIDOGREL BISULFATE, MISOPROSTOL, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ERGOCALCIFEROL, CICLESONIDE, VEDOLIZUMAB, TERBUTALINE SULFATE, |
||||
| 157 | 26932379 |
US |
1 | |
Pruritus, Fatigue, Cough, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 158 | 26932406 |
US |
||
Dry mouth, Dry throat, Cough, |
||||
TIOTROPIUM BROMIDE, |
||||
| 159 | 26932660 |
US |
29 | |
Eye haemorrhage, Ocular hyperaemia, Cough, |
||||
DUPILUMAB, |
||||
| 160 | 26932759 |
US |
2 | |
Pulmonary vascular resistance abnormality, Headache, Pain in jaw, Heart rate irregular, Pulmonary function test decreased, Throat irritation, Cough, Throat tightness, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MONTELUKAST SODIUM, PREDNISONE, METHOCARBAMOL, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, EMPAGLIFLOZIN, LORAZEPAM, PRAVASTATIN SODIUM, ERGOCALCIFEROL, ALBUTEROL SULFATE, ALLOPURINOL, GABAPENTIN, OXYGEN, 0XYGEN, COLCHICINE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, SPIRONOLACTONE, FUROSEMIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, GLIPIZIDE, TIRZEPATIDE, |
||||
| 161 | 26932898 |
67 | ||
Cough, |
||||
LISINOPRIL, GLIPIZIDE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 162 | 26932901 |
72 | ||
Cough, Pollakiuria, |
||||
BENAZEPRIL HYDROCHLORIDE, AMLODIPINE, |
||||
| 163 | 26932915 |
56 | ||
Cough, |
||||
BENAZEPRIL HYDROCHLORIDE, LISINOPRIL, ROSUVASTATIN, HYOSCYAMINE SULFATE, ESCITALOPRAM, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, OMEPRAZOLE MAGNESIUM, MONTELUKAST SODIUM, ERGOCALCIFEROL, |
||||
| 164 | 26932921 |
72 | ||
Cough, Pollakiuria, |
||||
BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, |
||||
| 165 | 26932923 |
|||
Headache, Cough, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, |
||||
| 166 | 26932956 |
68 | ||
Blood pressure increased, Cough, |
||||
METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, OLMESARTAN MEDOXOMIL, HYDROCHLOROTHIAZIDE, URSODIOL, URSOSIOL, |
||||
| 167 | 26932966 |
|||
Cough, Drug ineffective, |
||||
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, VALSARTAN AND HYDROCHLOROTHIAZIDE, |
||||
| 168 | 26932968 |
|||
Cough, |
||||
BENAZEPRIL HYDROCHLORIDE, |
||||
| 169 | 26932980 |
|||
Cough, Insomnia, |
||||
METOPROLOL TARTRATE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, CANDESARTAN CILEXETIL, LOSARTAN POTASSIUM, |
||||
| 170 | 26933030 |
EU |
72 | 1 |
Pulmonary fibrosis, Dependence on oxygen therapy, Dyspnoea exertional, Cough, Abnormal loss of weight, |
||||
ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ALLOPURINOL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 171 | 26933092 |
US |
2 | |
Illness, Cough, General physical health deterioration, Product dose omission issue, |
||||
BRENSOCATIB, BRENSOCATIB, |
||||
| 172 | 26933208 |
CA |
25 | |
Haematochezia, Discomfort, Harvey-Bradshaw index increased, Anal fissure, Anal fistula, Cough, Muscle spasms, Nasopharyngitis, Urinary tract infection, Abdominal pain, Weight increased, Off label use, Inappropriate schedule of product administration, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, METHOTREXATE, METHOTREXATE SODIUM, |
||||
| 173 | 26933261 |
EU |
57 | 2 |
Multiple organ dysfunction syndrome, Breast cancer metastatic, Malignant neoplasm progression, Emphysema, Femoral neck fracture, Cough, Dyspnoea, Back pain, |
||||
FULVESTRANT, FULVESTRANT, FULVESTRANT, RIBOCICLIB, RIBOCICLIB, |
||||
| 174 | 26933366 |
US |
68 | 2 |
Back pain, Cough, |
||||
DUPILUMAB, TIRZEPATIDE, |
||||
| 175 | 26933394 |
US |
58 | |
Nasopharyngitis, Rhinorrhoea, Cough, Arthralgia, |
||||
DUPILUMAB, |
||||
| 176 | 26933404 |
US |
76 | 2 |
Dyspnoea exertional, Chest discomfort, Cough, Productive cough, Peripheral swelling, Swelling, |
||||
DUPILUMAB, |
||||
| 177 | 26933447 |
US |
66 | 2 |
Cough, Dyspnoea, Tinnitus, Dry mouth, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 178 | 26933464 |
US |
55 | 2 |
Cough, Dyspnoea, Dizziness, Fatigue, Productive cough, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 179 | 26933502 |
US |
74 | 2 |
Cough, Nasal congestion, Fatigue, Dizziness, |
||||
DUPILUMAB, |
||||
| 180 | 26933523 |
US |
26 | 2 |
Bronchitis, Cough, Injection site pain, |
||||
DUPILUMAB, |
||||
| 181 | 26933563 |
US |
71 | 1 |
Cough, Gastrointestinal disorder, Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, FINASTERIDE, |
||||
| 182 | 26933725 |
US |
75 | 2 |
Fatigue, Asthenia, Chromaturia, Blood urine present, Productive cough, Cough, Urinary tract infection, |
||||
DUPILUMAB, |
||||
| 183 | 26926636 |
US |
31 | 2 |
Wheezing, Cough, Sputum discoloured, Incorrect dose administered, |
||||
DUPILUMAB, |
||||
| 184 | 26926732 |
|||
Cough, |
||||
BENAZEPRIL HYDROCHLORIDE, AMLODIPINE BESYLATE, |
||||
| 185 | 26926735 |
|||
Cough, |
||||
BENAZEPRIL HYDROCHLORIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, FENOFIBRATE, |
||||
| 186 | 26926747 |
|||
Cough, |
||||
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, VITAMIN C, |
||||
| 187 | 26926756 |
|||
Cough, Dyspnoea, |
||||
BENAZEPRIL HYDROCHLORIDE, |
||||
| 188 | 26926757 |
|||
Cough, |
||||
BENAZEPRIL HYDROCHLORIDE, |
||||
| 189 | 26926766 |
|||
Vision blurred, Oropharyngeal pain, Rhinorrhoea, Sneezing, Cough, |
||||
BENAZEPRIL HYDROCHLORIDE, |
||||
| 190 | 26926779 |
|||
Cough, |
||||
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE, |
||||
| 191 | 26926794 |
|||
Cough, |
||||
BENAZEPRIL HYDROCHLORIDE, METOPROLOL SUCCINATE, LANSOPRAZOLE, |
||||
| 192 | 26926819 |
CA |
60 | 1 |
Asthma, Cough, Disease recurrence, Drug dependence, Dyspnoea, Eosinophil count increased, Eosinophilic granulomatosis with polyangiitis, Full blood count abnormal, Gastrooesophageal reflux disease, Haemoptysis, Hypoaesthesia, Malaise, Neuropathy peripheral, Paraesthesia, Productive cough, Therapeutic product effect incomplete, Upper respiratory tract infection, Vasculitis, Visual impairment, |
||||
FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, MEPOLIZUMAB, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, AZATHIOPRINE SODIUM, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, BUDESONIDE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, GLYCOPYRROLATE, GLYCOPYRROLATE, GLYCOPYRROLATE, AZATHIOPRINE, AZATHIOPRINE, AZATHIOPRINE, RANIBIZUMAB, RANIBIZUMAB, MOMETASONE, MOMETASONE FUROATE, MOMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 193 | 26926912 |
US |
74 | 1 |
Cough, Dyspnoea, Dizziness, |
||||
DUPILUMAB, |
||||
| 194 | 26927010 |
US |
1 | |
Cough, Throat irritation, Oropharyngeal pain, Diarrhoea, Asthenia, Dysphagia, Dizziness, Product dose omission issue, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, NINTEDANIB, TREPROSTINIL, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, MIRTAZAPINE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, FLUTICASONE PROPIONATE, FAMOTIDINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OXYGEN, 0XYGEN, |
||||
| 195 | 26927087 |
US |
58 | 2 |
Cough, Injury associated with device, Device defective, |
||||
INSULIN GLARGINE, |
||||
| 196 | 26927262 |
US |
16 | 1 |
Cough, Eosinophilic oesophagitis, Injection site pain, Screaming, Injection site vesicles, |
||||
DUPILUMAB, |
||||
| 197 | 26927317 |
US |
86 | 2 |
Knee arthroplasty, Tricuspid valve incompetence, Carotid artery occlusion, Left ventricular failure, Hypothyroidism, Dementia Alzheimer^s type, Mitral valve incompetence, Arteriosclerosis coronary artery, Type IIa hyperlipidaemia, Carotid artery stenosis, Type 2 diabetes mellitus, Fall, Hip arthroplasty, Alcohol abuse, Aortic valve stenosis, Essential hypertension, Back pain, Anaemia of chronic disease, Muscular weakness, Cough, Rhinitis allergic, Vitamin D deficiency, Nicotine dependence, Anaemia, Lumbosacral plexopathy, Peripheral vascular disorder, Constipation, Intervertebral disc degeneration, Cardiomegaly, Physical examination abnormal, Respiratory disorder, Vitamin B complex deficiency, Osteoarthritis, Cardiovascular symptom, Arthralgia, |
||||
DENOSUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CELECOXIB, ATORVASTATIN CALCIUM, ERGOCALCIFEROL, |
||||
| 198 | 26927489 |
US |
29 | 2 |
Hypertension, Abdominal pain, Vomiting, Hypophagia, Decreased appetite, Cough, Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 199 | 26927719 |
US |
61 | 2 |
Dermatitis atopic, Wheezing, Cough, |
||||
DUPILUMAB, |
||||
| 200 | 26927741 |
US |
83 | 2 |
Gastrooesophageal reflux disease, Cough, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30